Drug
5 Asa
5 Asa: highest development phase Phase 3, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| 5 ASA, enemas, suppositories, corticosteroids NCT00269438 | Phase 3 | Ulcerative Colitis |
Latest
No recent events.
Follow 5 Asa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.